Also trades as: EW.SW (SIX)

$85.78

+2.58 (+3.10%)

Weekly Expected Move ±5.1%

$73 $77 $81 $86 $90

NYSE · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 67 · $49.4B mcap · 568M float · 0.869% daily turnover · Short 42% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

58.1 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 21.1% · 5Y Avg: 52.6%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EW has a Narrow competitive edge (58.1/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 21.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$85

Low

$96

Avg Target

$110

High

Based on 5 analysts since Apr 23, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 32Hold: 16Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$95.50

Analysts6

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-04-27	Barclays	—	$104	$110	+6	+30.7%	$84.15
2026-04-24	Truist Financial	—	$89	$90	+1	+8.2%	$83.15
2026-04-24	Evercore ISI	Vijay Kumar	$94	$93	-1	+11.9%	$83.12
2026-04-24	BTIG	—	$103	$100	-3	+25.4%	$79.72
2026-04-24	Canaccord Genuity	William Plovanic	$87	$85	-2	+6.6%	$79.72
2026-04-13	Mizuho Securities	—	$105	$95	-10	+22.9%	$77.28
2026-02-11	Truist Financial	Richard Newitter	$92	$89	-3	+15.8%	$76.85
2026-02-11	Goldman Sachs	David Roman	$108	$95	-13	+23.3%	$77.05
2026-02-11	Piper Sandler	—	$98	$100	+2	+29.8%	$77.05
2026-02-04	UBS	Danielle Antalffy	$95	$94	-1	+15.2%	$81.62
2026-01-20	Stifel Nicolaus	—	$105	$110	+5	+30.4%	$84.35
2026-01-20	Piper Sandler	—	$73	$98	+25	+16.2%	$84.35
2026-01-12	UBS	Danielle Antalffy	$92	$95	+3	+13.7%	$83.58
2026-01-12	Robert W. Baird	—	$87	$90	+3	+7.5%	$83.69
2026-01-12	Barclays	—	$103	$104	+1	+22.2%	$85.13
2026-01-09	Goldman Sachs	David Roman	$104	$108	+4	+27.7%	$84.58
2026-01-07	Stifel Nicolaus	Rick Wise	$100	$105	+5	+22.3%	$85.85
2026-01-05	Evercore ISI	—	$88	$94	+6	+11.4%	$84.34
2025-12-18	Wells Fargo	—	$96	$100	+4	+17.9%	$84.84
2025-12-17	Canaccord Genuity	William Plovanic	$89	$87	-2	+2.0%	$85.32
2025-12-16	Robert W. Baird	David Rescott	$88	$87	-1	+4.3%	$83.38
2025-12-08	Barclays	—	$99	$103	+4	+19.5%	$86.19
2025-12-05	UBS	—	$90	$92	+2	+6.3%	$86.58
2025-12-05	RBC Capital	Shagun Singh	$95	$100	+5	+14.5%	$87.33
2025-12-05	Robert W. Baird	David Rescott	$83	$88	+5	+2.6%	$85.78
2025-12-05	Canaccord Genuity	William Plovanic	$84	$89	+5	+3.8%	$85.78
2025-12-05	Wells Fargo	Larry Biegelsen	$80	$96	+16	+11.9%	$85.78
2025-12-05	Stifel Nicolaus	Rick Wise	$85	$100	+15	+16.6%	$85.78
2025-12-05	Truist Financial	Richard Newitter	$87	$92	+5	+7.3%	$85.78
2025-12-04	BTIG	Marie Thibault	Initiated	$103	—	+20.1%	$85.78
2025-11-03	Bernstein	Lee Hambright	$74	$90	+16	+9.2%	$82.45
2025-11-03	UBS	—	Initiated	$90	—	+9.2%	$82.45
2025-11-03	Canaccord Genuity	William Plovanic	$75	$84	+9	+1.9%	$82.45
2025-11-03	Raymond James	Jayson Bedford	$83	$96	+13	+16.4%	$82.45
2025-10-31	National Bank	—	Initiated	$92	—	+11.6%	$82.46
2025-10-31	Goldman Sachs	—	$80	$104	+24	+23.1%	$84.48
2025-10-31	RBC Capital	—	$101	$95	-6	+14.1%	$83.29
2025-10-31	Robert W. Baird	David Rescott	$73	$83	+10	-0.3%	$83.29
2025-10-31	Barclays	—	$80	$99	+19	+18.6%	$83.48
2025-10-29	Jefferies	Matthew Taylor	$70	$98	+28	+19.2%	$82.19
2025-10-28	Truist Financial	—	$82	$87	+5	+4.7%	$83.08
2025-10-27	Truist Financial	—	$78	$82	+4	+1.5%	$80.82
2025-10-07	Evercore ISI	—	$126	$88	-38	+14.9%	$76.56
2025-09-22	Stifel Nicolaus	Rick Wise	$90	$85	-5	+14.2%	$74.41
2025-04-25	Canaccord Genuity	William Plovanic	$68	$75	+7	-1.4%	$76.04
2025-01-29	Stifel Nicolaus	Rick Wise	$70	$90	+20	+26.5%	$71.13
2025-01-08	Bernstein	Lee Hambright	$72	$74	+2	-0.2%	$74.15
2024-12-05	Bernstein	Lee Hambright	Initiated	$72	—	-0.9%	$72.62
2024-12-05	Truist Financial	Richard Newitter	$71	$78	+7	+7.4%	$72.64
2024-12-05	Canaccord Genuity	William Plovanic	$66	$68	+2	-7.2%	$73.25

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EW receives an overall rating of B+. Strongest factors: ROE (4/5), ROA (5/5). Areas of concern: P/E (1/5), P/B (2/5).

Rating Change History

Date	From	To
2026-05-06	C-	B+
2026-04-27	B	C-
2026-04-01	B+	B
2026-03-06	B	B+
2026-03-02	B+	B
2026-02-26	C-	B+
2026-02-11	B+	C-
2026-01-30	A-	B+
2026-01-28	B+	A-
2026-01-26	A-	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 65 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. EW scores highest in Safety (100/100) and lowest in Growth (32/100). An overall grade of A+ places EW among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

10.97

Safe Zone

Piotroski F-Score

6/9

✓ ✓ ✗ ✓ ✓ ✗ ✓ ✗ ✓

Beneish M-Score

-2.34

Unlikely Manipulator

Ohlson O-Score

-10.46

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA+

Score: 92.8/100

Trend: Stable

Earnings Quality

100/100

OCF/NI: 1.24x

Accruals: -2.0%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EW scores 10.97, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EW scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. EW's score of -2.34 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EW's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EW receives an estimated rating of AA+ (score: 92.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). EW's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

45.46x

PEG

-0.62x

P/S

7.84x

P/B

4.81x

P/FCF

42.68x

P/OCF

34.23x

EV/EBITDA

29.94x

EV/Revenue

6.82x

EV/EBIT

32.67x

EV/FCF

39.45x

Earnings Yield

2.35%

FCF Yield

2.34%

Shareholder Yield

0.88%

Graham Number

$27.45

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 45.5x earnings, EW is priced for high growth expectations. Graham's intrinsic value formula yields $27.45 per share, 212% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.842

NI / EBT

Interest Burden

0.987

EBT / EBIT

EBIT Margin

0.209

EBIT / Rev

Asset Turnover

0.471

Rev / Assets

Equity Multiplier

1.316

Assets / Equity

ROE

10.7%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EW's ROE of 10.7% is driven by Asset Turnover (0.471), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

$16.00

Price/Value

5.01x

Margin of Safety

-400.63%

Premium

400.63%

Assessment

Overvalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with EW's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. EW trades at a 401% premium to its adjusted intrinsic value of $16.00, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 45.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$85.77

Median 1Y

$84.55

5th Pctile

$47.78

95th Pctile

$149.55

Ann. Volatility

34.3%

Analyst Target

$95.50

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Mr. Zovighian Chief Executive Officer and Director	$1,192,500	$7,167,024	$17,454,255
Mr. Ullem Corporate Vice President, Chief Financial Officer	$807,898	$2,205,238	$6,050,554
Mr. Wood Corporate rporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$635,919	$1,818,499	$4,854,339
Mr. Chopra Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies	$671,042	$1,764,066	$4,695,742
Mr. Bobo Corporate Vice President, Strategy & Corporate Development	$759,783	$1,378,274	$4,223,365
Ms. Brüls Corporate Vice President, EMEACLA	$726,586	$1,020,334	$3,732,107

CEO Pay Ratio

134:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $17,454,255

Avg Employee Cost (SGA/emp): $130,325

Employees: 16,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

16,000

+1.3% YoY

Revenue / Employee

$379,225

Rev: $6,067,600,000

Profit / Employee

$67,094

NI: $1,073,500,000

SGA / Employee

$130,325

Avg labor cost proxy

R&D / Employee

$67,450

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
ROE	33.5%	33.9%	28.9%	29.6%	28.0%	28.0%	26.1%	25.6%	23.9%	24.6%	22.5%	22.7%	23.6%	66.7%	50.1%	50.2%	49.8%	16.4%	10.5%	10.7%	10.75%
ROA	21.3%	21.5%	19.1%	19.5%	18.5%	18.5%	18.1%	17.7%	16.5%	17.0%	15.9%	16.0%	16.7%	47.1%	37.2%	37.3%	37.0%	12.2%	8.0%	8.2%	8.17%
ROIC	35.5%	36.6%	28.1%	28.8%	28.2%	28.3%	27.7%	27.2%	26.4%	25.3%	22.9%	22.3%	22.4%	22.7%	18.6%	18.9%	19.1%	19.8%	19.7%	21.1%	21.12%
ROCE	26.2%	26.6%	22.9%	23.5%	22.4%	22.6%	24.3%	23.8%	21.2%	20.9%	17.5%	17.2%	18.5%	18.6%	13.8%	14.3%	14.1%	13.7%	10.4%	11.1%	11.07%
Gross Margin	76.3%	77.0%	76.6%	77.1%	79.2%	78.7%	78.1%	75.4%	79.1%	78.1%	80.2%	78.2%	78.5%	80.6%	78.9%	78.7%	77.6%	77.9%	78.3%	78.2%	78.21%
Operating Margin	32.7%	31.1%	27.2%	32.5%	31.2%	32.4%	30.4%	27.6%	28.6%	27.9%	28.2%	26.7%	26.3%	25.9%	22.6%	27.9%	28.1%	27.4%	23.6%	31.2%	31.22%
Net Margin	35.6%	26.0%	25.2%	27.9%	29.6%	26.0%	29.5%	23.3%	23.7%	31.0%	29.2%	26.5%	26.2%	2.3%	27.8%	25.3%	21.5%	18.7%	5.8%	23.1%	23.09%
EBITDA Margin	42.9%	33.1%	31.4%	35.7%	36.9%	34.1%	37.2%	30.2%	24.0%	34.1%	31.9%	30.8%	30.8%	31.7%	34.9%	33.3%	26.1%	25.0%	8.5%	31.2%	31.22%
FCF Margin	21.3%	27.7%	26.8%	26.7%	23.5%	19.4%	17.7%	17.9%	12.6%	14.7%	12.0%	4.6%	10.3%	9.4%	5.3%	11.8%	10.7%	13.7%	22.0%	17.3%	17.28%
OCF Margin	29.3%	34.5%	33.1%	32.2%	28.6%	24.4%	22.6%	22.5%	17.3%	19.5%	17.0%	10.3%	16.6%	15.1%	9.9%	15.8%	14.0%	17.3%	26.3%	21.6%	21.55%
ROE 3Y Avg	snapshot only																				24.54%
ROE 5Y Avg	snapshot only																				25.12%
ROA 3Y Avg	snapshot only																				18.36%
ROIC 3Y Avg	snapshot only																				37.33%
ROIC Economic	snapshot only																				13.18%
Cash ROA	snapshot only																				9.92%
Cash ROIC	snapshot only																				19.93%
CROIC	snapshot only																				15.98%
NOPAT Margin	snapshot only																				22.83%
Pretax Margin	snapshot only																				20.59%
R&D / Revenue	snapshot only																				17.26%
SGA / Revenue	snapshot only																				33.98%
SBC / Revenue	snapshot only																				2.59%

Valuation

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	44.61	48.41	54.47	48.16	40.95	35.37	30.21	33.95	41.43	29.51	33.00	40.83	37.96	9.50	10.48	10.20	11.09	33.38	46.35	42.55	45.465
P/S Ratio	13.25	14.04	15.65	13.83	11.13	9.62	8.54	9.19	10.62	7.90	8.79	11.24	10.68	7.40	8.01	7.69	8.09	7.74	8.17	7.38	7.836
P/B Ratio	14.26	15.63	14.03	12.70	10.21	8.84	7.92	8.70	9.91	7.27	6.96	8.68	8.39	5.94	4.37	4.26	4.60	4.56	4.80	4.50	4.811
P/FCF	62.10	50.76	58.39	51.87	47.27	49.64	48.22	51.29	84.41	53.57	73.51	242.45	103.66	78.59	150.79	65.23	75.64	56.64	37.15	42.68	42.682
P/OCF	45.22	40.67	47.27	42.95	38.92	39.42	37.74	40.79	61.22	40.52	51.66	109.29	64.45	48.94	80.61	48.62	57.84	44.80	31.09	34.23	34.228
EV/EBITDA	35.53	38.23	43.31	38.16	32.01	27.43	23.47	26.35	33.51	24.86	28.69	36.65	32.97	23.09	23.13	21.74	23.95	24.27	33.12	29.94	29.939
EV/Revenue	13.10	13.90	15.50	13.69	10.98	9.48	8.44	9.09	10.52	7.80	8.61	11.06	10.50	7.22	7.41	7.10	7.51	7.18	7.59	6.82	6.819
EV/EBIT	38.86	41.92	47.44	41.75	35.14	30.12	25.69	28.89	37.04	27.42	31.73	40.53	36.28	25.35	25.38	23.75	26.18	26.66	37.32	32.67	32.670
EV/FCF	61.42	50.25	57.83	51.33	46.65	48.89	47.67	50.76	83.64	52.91	72.01	238.47	101.90	76.70	139.49	60.22	70.25	52.57	34.51	39.45	39.450
Earnings Yield	2.2%	2.1%	1.8%	2.1%	2.4%	2.8%	3.3%	2.9%	2.4%	3.4%	3.0%	2.4%	2.6%	10.5%	9.5%	9.8%	9.0%	3.0%	2.2%	2.3%	2.35%
FCF Yield	1.6%	2.0%	1.7%	1.9%	2.1%	2.0%	2.1%	1.9%	1.2%	1.9%	1.4%	0.4%	1.0%	1.3%	0.7%	1.5%	1.3%	1.8%	2.7%	2.3%	2.34%
Price/Tangible Book	snapshot only																				6.250
EV/OCF	snapshot only																				31.636
EV/Gross Profit	snapshot only																				8.740
Acquirers Multiple	snapshot only																				24.688
Shareholder Yield	snapshot only																				0.88%
Graham Number	snapshot only																				$27.45

Leverage & Solvency

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Current Ratio	3.46	3.46	3.08	3.08	3.08	3.08	3.03	3.03	3.03	3.03	3.38	3.38	3.38	3.38	4.18	4.18	4.18	4.18	3.72	3.72	3.716
Quick Ratio	2.56	2.56	2.38	2.38	2.38	2.38	2.17	2.17	2.17	2.17	2.62	2.62	2.62	2.62	3.45	3.45	3.45	3.45	3.09	3.09	3.095
Debt/Equity	0.15	0.15	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.10	0.10	0.10	0.10	0.07	0.07	0.07	0.07	0.07	0.07	0.068
Net Debt/Equity	-0.15	-0.15	-0.13	-0.13	-0.13	-0.13	-0.09	-0.09	-0.09	-0.09	-0.14	-0.14	-0.14	-0.14	-0.33	-0.33	-0.33	-0.33	-0.34	-0.34	-0.341
Debt/Assets	0.10	0.10	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.05	0.05	0.05	0.05	0.05	0.05	0.051
Debt/EBITDA	0.38	0.38	0.37	0.36	0.38	0.37	0.36	0.36	0.41	0.41	0.43	0.44	0.41	0.41	0.40	0.39	0.39	0.40	0.51	0.49	0.491
Net Debt/EBITDA	-0.39	-0.38	-0.41	-0.40	-0.42	-0.42	-0.27	-0.28	-0.31	-0.31	-0.60	-0.61	-0.57	-0.57	-1.87	-1.81	-1.84	-1.88	-2.53	-2.45	-2.453
Interest Coverage	296.57	234.58	231.00	247.31	293.63	511.42	842.62	1573.64	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.58	1.58	1.46	1.46	1.46	1.46	1.43	1.43	1.43	1.43	1.41	1.41	1.41	1.41	1.31	1.31	1.31	1.31	1.32	1.32	1.325
Cash Ratio	snapshot only																				2.330
Cash to Debt	snapshot only																				5.992
FCF to Debt	snapshot only																				1.545
Defensive Interval	snapshot only																				590.5 days

Efficiency & Turnover

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	0.72	0.74	0.66	0.68	0.68	0.68	0.64	0.66	0.65	0.64	0.60	0.58	0.59	0.60	0.49	0.49	0.51	0.52	0.45	0.47	0.471
Inventory Turnover	1.66	1.68	1.60	1.63	1.58	1.55	1.46	1.52	1.51	1.50	1.30	1.22	1.25	1.24	1.15	1.16	1.21	1.29	1.20	1.25	1.253
Receivables Turnover	9.31	9.63	9.54	9.77	9.76	9.78	8.79	8.98	8.85	8.73	7.44	7.26	7.39	7.55	7.90	8.02	8.24	8.52	9.57	9.94	9.937
Payables Turnover	6.35	6.42	6.11	6.21	6.01	5.91	5.75	6.01	5.94	5.90	5.94	5.58	5.72	5.67	5.95	6.01	6.25	6.67	6.25	6.52	6.524
DSO	39	38	38	37	37	37	42	41	41	42	49	50	49	48	46	45	44	43	38	37	36.7 days
DIO	220	218	228	224	232	236	250	239	242	244	282	300	292	295	318	315	303	284	304	291	291.4 days
DPO	58	57	60	59	61	62	63	61	61	62	61	65	64	64	61	61	58	55	58	56	55.9 days
Cash Conversion Cycle	202	199	206	203	208	211	228	219	222	224	269	285	278	279	303	299	289	272	284	272	272.2 days
Fixed Asset Turnover	snapshot only																				3.292
Operating Cycle	snapshot only																				327.8 days
Cash Velocity	snapshot only																				1.491
Capital Intensity	snapshot only																				2.173

Growth (YoY)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue	14.0%	16.6%	19.3%	19.7%	8.7%	5.3%	2.9%	2.7%	1.3%	-0.3%	-2.2%	-6.6%	-3.6%	-0.2%	3.6%	7.9%	8.8%	10.3%	11.2%	13.8%	13.81%
Net Income	96.7%	86.0%	82.5%	80.8%	-0.5%	-1.3%	1.3%	-3.2%	-4.5%	-1.9%	-7.9%	-5.0%	5.8%	1.9%	2.0%	2.0%	1.8%	-67.2%	-74.4%	-73.8%	-73.84%
EPS	93.7%	85.8%	82.5%	81.3%	0.0%	-0.1%	3.8%	-0.3%	-2.0%	0.5%	-6.4%	-4.0%	6.9%	2.0%	2.1%	2.0%	1.9%	-66.5%	-74.0%	-73.5%	-73.52%
FCF	12.1%	1.0%	1.2%	99.3%	20.0%	-26.2%	-32.0%	-31.0%	-45.9%	-24.2%	-34.0%	-75.8%	-21.0%	-36.3%	-53.9%	1.7%	12.9%	60.1%	3.6%	66.8%	66.82%
EBITDA	94.0%	84.7%	77.7%	76.5%	1.1%	0.0%	3.4%	-1.2%	-7.3%	-9.4%	-18.4%	-18.4%	-2.2%	-0.5%	10.6%	16.8%	7.1%	4.4%	-20.4%	-20.7%	-20.65%
Op. Income	28.9%	26.8%	24.3%	24.9%	5.0%	2.6%	5.6%	0.8%	-1.4%	-7.5%	-13.2%	-14.3%	-11.6%	-6.7%	-6.3%	-0.5%	4.6%	9.5%	17.2%	22.4%	22.37%
OCF Growth	snapshot only																				55.06%
Asset Growth	snapshot only																				4.92%
Equity Growth	snapshot only																				3.39%
Debt Growth	snapshot only																				0.77%
Shares Change	snapshot only																				-1.21%

Growth (CAGR)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue 3Y	11.5%	11.9%	12.0%	11.9%	10.5%	8.9%	7.4%	7.1%	7.9%	7.0%	6.3%	4.7%	2.0%	1.6%	1.4%	1.1%	2.0%	3.1%	4.1%	4.6%	4.65%
Revenue 5Y	12.4%	12.2%	12.0%	11.2%	10.6%	10.1%	9.4%	9.8%	8.9%	8.0%	7.2%	6.1%	5.7%	5.2%	4.6%	4.3%	5.6%	6.1%	6.7%	7.1%	7.10%
EPS 3Y	29.0%	25.8%	28.0%	26.7%	26.8%	24.3%	14.6%	11.8%	23.8%	23.1%	21.0%	20.2%	1.6%	43.8%	43.8%	42.7%	44.8%	-0.1%	-9.4%	-8.3%	-8.26%
EPS 5Y	23.4%	22.6%	22.2%	19.3%	16.0%	15.3%	20.7%	21.3%	16.0%	14.9%	15.3%	14.3%	16.4%	41.7%	33.9%	32.4%	42.5%	13.1%	7.1%	6.9%	6.90%
Net Income 3Y	28.1%	25.3%	27.7%	26.2%	26.2%	23.5%	13.3%	10.4%	23.2%	21.7%	19.4%	18.4%	0.2%	41.2%	40.5%	39.5%	41.7%	-2.2%	-11.1%	-9.8%	-9.79%
Net Income 5Y	22.6%	21.8%	21.4%	18.6%	15.2%	14.4%	19.6%	20.0%	14.9%	13.8%	14.2%	13.1%	15.2%	40.0%	31.9%	30.4%	41.0%	11.4%	5.4%	5.1%	5.13%
EBITDA 3Y	17.2%	16.7%	30.6%	30.6%	27.3%	24.8%	14.8%	11.4%	22.1%	18.7%	14.5%	12.5%	-2.9%	-3.4%	-2.3%	-2.0%	-1.0%	-2.0%	-10.4%	-8.9%	-8.89%
EBITDA 5Y	18.4%	18.0%	17.1%	15.2%	13.5%	13.0%	11.6%	11.9%	8.6%	7.5%	13.4%	12.4%	13.3%	11.8%	6.4%	5.7%	13.8%	11.7%	5.7%	5.7%	5.69%
Gross Profit 3Y	12.3%	12.7%	12.7%	12.5%	12.0%	11.0%	9.7%	9.1%	9.6%	8.3%	7.7%	6.5%	3.3%	2.9%	2.5%	2.2%	2.6%	3.3%	4.0%	4.7%	4.74%
Gross Profit 5Y	12.8%	13.0%	13.0%	12.1%	11.6%	11.2%	10.5%	10.9%	9.9%	8.9%	8.0%	7.0%	6.9%	6.7%	6.2%	5.9%	7.0%	7.1%	7.6%	7.9%	7.92%
Op. Income 3Y	15.6%	15.6%	13.8%	13.6%	13.5%	12.9%	12.5%	9.9%	10.1%	6.4%	4.4%	2.6%	-2.9%	-3.9%	-4.9%	-4.9%	-3.0%	-1.8%	-1.6%	1.4%	1.44%
Op. Income 5Y	16.9%	16.3%	15.3%	13.1%	11.0%	10.8%	10.7%	11.2%	9.9%	7.9%	6.2%	4.8%	5.0%	4.4%	3.0%	2.5%	4.3%	4.2%	4.6%	5.6%	5.61%
FCF 3Y	10.8%	22.6%	27.0%	39.8%	21.4%	8.9%	1.9%	-3.1%	-10.0%	4.6%	-0.9%	-30.7%	-20.0%	-29.1%	-40.9%	-23.0%	-21.6%	-8.2%	11.9%	3.4%	3.40%
FCF 5Y	19.5%	27.9%	23.6%	22.5%	18.4%	9.8%	2.9%	3.7%	-2.4%	0.6%	-1.7%	-14.5%	-5.2%	-9.0%	-20.3%	-9.6%	-8.3%	3.2%	15.6%	8.7%	8.74%
OCF 3Y	14.3%	20.8%	23.2%	30.5%	16.1%	6.9%	1.1%	-3.6%	-9.6%	-0.4%	-5.3%	-22.8%	-15.6%	-22.9%	-32.1%	-20.2%	-19.6%	-8.1%	9.4%	3.1%	3.12%
OCF 5Y	19.0%	23.7%	19.7%	18.9%	15.9%	9.3%	4.0%	3.9%	-0.5%	0.9%	-0.7%	-7.4%	-2.4%	-5.6%	-14.4%	-8.7%	-9.0%	-0.7%	8.6%	3.4%	3.43%
Assets 3Y	8.3%	8.3%	16.9%	16.9%	16.9%	16.9%	8.5%	8.5%	8.5%	8.5%	9.0%	9.0%	9.0%	9.0%	15.4%	15.4%	15.4%	15.4%	18.2%	18.2%	18.21%
Assets 5Y	12.3%	12.3%	13.5%	13.5%	13.5%	13.5%	7.8%	7.8%	7.8%	7.8%	12.0%	12.0%	12.0%	12.0%	15.0%	15.0%	15.0%	15.0%	13.6%	13.6%	13.61%
Equity 3Y	15.2%	15.2%	22.9%	22.9%	22.9%	22.9%	11.9%	11.9%	11.9%	11.9%	13.3%	13.3%	13.3%	13.3%	19.7%	19.7%	19.7%	19.7%	21.2%	21.2%	21.20%
Book Value 3Y	15.9%	15.6%	23.2%	23.4%	23.6%	23.7%	13.2%	13.3%	12.5%	13.2%	14.8%	15.0%	14.9%	15.4%	22.4%	22.4%	22.2%	22.2%	23.5%	23.3%	23.26%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	0.99	0.98	0.96	0.95	0.99	0.98	0.95	0.95	0.97	0.93	0.87	0.76	0.77	0.78	0.77	0.61	0.76	0.85	0.88	0.81	0.811
Earnings Stability	0.61	0.64	0.74	0.70	0.71	0.72	0.81	0.80	0.76	0.77	0.69	0.65	0.68	0.64	0.58	0.56	0.58	0.24	0.16	0.16	0.159
Margin Stability	0.99	0.99	0.98	0.98	0.98	0.98	0.97	0.98	0.98	0.98	0.98	0.98	0.98	0.97	0.97	0.97	0.98	0.98	0.98	0.98	0.979
Rev. Growth Consistency	1.00	1.00	1.00	0.50	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.000
Earn. Growth Consistency	1.00	1.00	0.50	0.50	0.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	0.00	0.00	0.00	0.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.50	1.00	0.99	0.99	0.99	0.98	0.99	0.97	0.98	0.98	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	0.35	0.40	0.42	0.42	1.00	0.99	0.99	0.97	0.95	0.98	0.92	0.95	0.94	0.02	0.01	0.01	0.05	0.00	0.00	0.00	0.000
ROE Trend	0.11	0.10	0.04	0.04	-0.00	-0.01	0.04	0.03	-0.05	-0.04	-0.05	-0.05	-0.02	0.38	0.18	0.18	0.18	-0.30	-0.21	-0.21	-0.210
Gross Margin Trend	0.01	0.02	0.02	0.02	0.03	0.02	0.03	0.02	0.01	0.01	0.01	0.02	0.01	0.02	0.01	0.01	0.01	-0.00	-0.00	-0.01	-0.010
FCF Margin Trend	0.02	0.10	0.09	0.07	0.02	-0.02	-0.03	-0.03	-0.10	-0.09	-0.10	-0.18	-0.08	-0.08	-0.10	0.01	-0.01	0.02	0.13	0.09	0.091
Sustainable Growth Rate	33.5%	33.9%	28.9%	29.6%	28.0%	28.0%	26.1%	25.6%	23.9%	24.6%	22.5%	22.7%	23.6%	66.7%	50.1%	50.2%	49.8%	16.4%	10.5%	10.7%	10.75%
Internal Growth Rate	27.1%	27.4%	23.6%	24.3%	22.7%	22.8%	22.1%	21.5%	19.8%	20.5%	18.9%	19.1%	20.0%	89.0%	59.3%	59.4%	58.7%	13.9%	8.7%	8.9%	8.90%

Cash Flow Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	0.99	1.19	1.15	1.12	1.05	0.90	0.80	0.83	0.68	0.73	0.64	0.37	0.59	0.19	0.13	0.21	0.19	0.75	1.49	1.24	1.243
FCF/OCF	0.73	0.80	0.81	0.83	0.82	0.79	0.78	0.80	0.73	0.76	0.70	0.45	0.62	0.62	0.53	0.75	0.76	0.79	0.84	0.80	0.802
FCF/Net Income	snapshot only																				0.997
OCF/EBITDA	snapshot only																				0.946
CapEx/Revenue	8.0%	6.9%	6.3%	5.5%	5.0%	5.0%	4.9%	4.6%	4.8%	4.7%	5.1%	5.6%	6.3%	5.7%	4.6%	4.0%	3.3%	3.6%	4.3%	4.3%	4.27%
CapEx/Depreciation	snapshot only																				2.243
Accruals Ratio	0.00	-0.04	-0.03	-0.02	-0.01	0.02	0.04	0.03	0.05	0.05	0.06	0.10	0.07	0.38	0.32	0.29	0.30	0.03	-0.04	-0.02	-0.020
Sloan Accruals	snapshot only																				0.002
Cash Flow Adequacy	snapshot only																				5.049
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	28.5%	28.2%	34.1%	40.0%	59.0%	65.6%	1.1%	1.1%	88.0%	90.7%	62.7%	44.6%	53.1%	36.3%	25.4%	31.5%	28.1%	7.9%	13.8%	37.6%	37.60%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.6%	0.6%	0.6%	0.8%	1.4%	1.9%	3.8%	3.1%	2.1%	3.1%	1.9%	1.1%	1.4%	3.8%	2.4%	3.1%	2.5%	0.2%	0.3%	0.9%	0.88%
Net Buyback Yield	0.6%	0.6%	0.6%	0.8%	1.4%	1.9%	3.8%	3.1%	2.1%	3.1%	1.9%	1.1%	1.4%	3.8%	2.4%	3.0%	2.3%	0.0%	0.0%	0.5%	0.54%
Total Shareholder Return	0.6%	0.6%	0.6%	0.8%	1.4%	1.9%	3.8%	3.1%	2.1%	3.1%	1.9%	1.1%	1.4%	3.8%	2.4%	3.0%	2.3%	0.0%	0.0%	0.5%	0.54%

DuPont Factors

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	0.88	0.88	0.88	0.88	0.87	0.87	0.86	0.86	0.90	0.94	0.98	1.01	0.97	2.72	2.69	2.59	2.55	0.87	0.84	0.84	0.842
Interest Burden (EBT/EBIT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.01	0.97	0.97	1.00	0.99	1.03	0.99	0.987
EBIT Margin	0.34	0.33	0.33	0.33	0.31	0.31	0.33	0.31	0.28	0.28	0.27	0.27	0.29	0.28	0.29	0.30	0.29	0.27	0.20	0.21	0.209
Asset Turnover	0.72	0.74	0.66	0.68	0.68	0.68	0.64	0.66	0.65	0.64	0.60	0.58	0.59	0.60	0.49	0.49	0.51	0.52	0.45	0.47	0.471
Equity Multiplier	1.57	1.57	1.51	1.51	1.51	1.51	1.44	1.44	1.44	1.44	1.42	1.42	1.42	1.42	1.35	1.35	1.35	1.35	1.32	1.32	1.316

Per Share

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$2.32	$2.34	$2.38	$2.44	$2.32	$2.34	$2.47	$2.44	$2.28	$2.35	$2.31	$2.34	$2.43	$6.95	$7.07	$7.11	$7.05	$2.33	$1.84	$1.88	$1.88
Book Value/Share	$7.26	$7.24	$9.23	$9.27	$9.31	$9.34	$9.42	$9.51	$9.51	$9.53	$10.96	$11.01	$11.00	$11.12	$16.93	$17.01	$17.01	$17.07	$17.77	$17.80	$17.83
Tangible Book/Share	$4.87	$4.86	$6.87	$6.90	$6.93	$6.96	$7.07	$7.13	$7.14	$7.15	$8.41	$8.45	$8.45	$8.54	$11.93	$11.99	$11.98	$12.03	$12.79	$12.81	$12.81
Revenue/Share	$7.82	$8.06	$8.28	$8.51	$8.54	$8.59	$8.73	$9.00	$8.88	$8.77	$8.68	$8.50	$8.65	$8.92	$9.24	$9.42	$9.67	$10.05	$10.43	$10.86	$10.88
FCF/Share	$1.67	$2.23	$2.22	$2.27	$2.01	$1.66	$1.55	$1.61	$1.12	$1.29	$1.04	$0.39	$0.89	$0.84	$0.49	$1.11	$1.03	$1.37	$2.29	$1.88	$1.88
OCF/Share	$2.29	$2.78	$2.74	$2.74	$2.44	$2.10	$1.98	$2.03	$1.54	$1.71	$1.48	$0.87	$1.43	$1.35	$0.92	$1.49	$1.35	$1.74	$2.74	$2.34	$2.35
Cash/Share	$2.23	$2.22	$2.32	$2.33	$2.34	$2.35	$1.97	$1.99	$1.99	$1.99	$2.69	$2.70	$2.70	$2.73	$6.73	$6.76	$6.76	$6.79	$7.27	$7.28	$6.34
EBITDA/Share	$2.88	$2.93	$2.96	$3.05	$2.93	$2.97	$3.14	$3.11	$2.79	$2.75	$2.60	$2.56	$2.75	$2.79	$2.96	$3.08	$3.03	$2.97	$2.39	$2.47	$2.47
Debt/Share	$1.10	$1.10	$1.09	$1.10	$1.10	$1.11	$1.12	$1.13	$1.13	$1.13	$1.13	$1.13	$1.13	$1.15	$1.19	$1.19	$1.19	$1.20	$1.21	$1.21	$1.21
Net Debt/Share	$-1.12	$-1.12	$-1.23	$-1.23	$-1.24	$-1.24	$-0.85	$-0.86	$-0.86	$-0.86	$-1.56	$-1.57	$-1.57	$-1.58	$-5.55	$-5.57	$-5.57	$-5.59	$-6.05	$-6.06	$-6.06

Academic Models

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	10.969
Altman Z-Prime	snapshot only																				20.927
Piotroski F-Score	7	8	8	8	6	5	6	4	4	4	6	6	5	7	6	7	6	5	6	6	6
Beneish M-Score	-2.30	-2.63	-2.42	-2.38	-2.34	-2.20	-2.29	-2.32	-2.20	-2.24	-2.06	-1.86	-2.01	-0.65	-1.20	-1.32	-1.29	-2.35	-2.45	-2.34	-2.343
Ohlson O-Score	snapshot only																				-10.459
ROIC (Greenblatt)	snapshot only																				19.23%
Net-Net WC	snapshot only																				$5.82
EVA	snapshot only																				$757722912.17

Credit

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only																				AA+
Credit Score	95.93	95.69	95.82	95.63	96.02	95.92	96.84	95.90	93.62	93.43	93.35	95.06	93.40	93.06	95.19	93.17	93.52	93.02	93.40	92.78	92.783
Credit Grade	snapshot only																				2
Credit Trend	snapshot only																				-0.390
Implied Spread (bps)	snapshot only																				65.000
Industry Credit Rank	snapshot only																				86
Sector Credit Rank	snapshot only																				88

EW NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet